User profiles for Pritesh Jain

Preetesh Jain MBBS,MD,DM,PhD

- Verified email at mdanderson.org - Cited by 7146

pritesh jain

- Verified email at patelcollege.com - Cited by 560

Pritesh Jain

- Verified email at ohri.ca - Cited by 500

A survey paper on cloud computing

S Patidar, D Rane, P Jain - 2012 second international …, 2012 - ieeexplore.ieee.org
Cloud computing is the biggest buzz in the computer world these days -- maybe too big of a
buzz. Cloud computing means different things to different people. Cloud computing is not a …

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

…, LE Fayad, S Ahmed, SP Iyer, RE Steiner, P Jain… - Nature medicine, 2023 - nature.com
Increasing evidence suggests that the gut microbiome may modulate the efficacy of cancer
immunotherapy. In a B cell lymphoma patient cohort from five centers in Germany and the …

MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension

H Shen, J Zhang, C Wang, PP Jain, M Xiong, X Shi… - Circulation, 2020 - Am Heart Assoc
Background: Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II, a potent
vasoconstrictor, to angiotensin-(1–7) and is also a membrane protein that enables coronavirus …

Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib

P Jain, M Keating, W Wierda, Z Estrov… - Blood, The Journal …, 2015 - ashpublications.org
Ibrutinib is a Bruton tyrosine kinase inhibitor approved for the treatment of patients with
relapsed refractory chronic lymphocytic leukemia (RR-CLL). We describe the characteristics, …

Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical …

…, G Borthakur, N Pemmaraju, N Daver, P Jain… - The Lancet …, 2015 - thelancet.com
Background Tyrosine-kinase inhibitors improve overall survival in patients with chronic
myeloid leukaemia in chronic phase (CML-CP). Survival compared with the general population …

C hronic lymphocytic leukemia (CLL)—T hen and now

KR Rai, P Jain - American journal of hematology, 2016 - Wiley Online Library
The field of chronic lymphocytic leukemia (CLL) has witnessed considerable change since
the time clinical staging was introduced in clinical practice in 1975. Over the years, the …

Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management

P Jain, M Wang - American journal of hematology, 2019 - Wiley Online Library
Unprecedented advances in our understanding of the pathobiology, prognostication, and
therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years. …

TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes

TM Kadia, P Jain, F Ravandi, G Garcia‐Manero… - Cancer, 2016 - Wiley Online Library
BACKGROUND Mutations in the tumor protein 53 (TP53) gene predict a poor prognosis in
patients with acute myeloid leukemia (AML). METHODS Peripheral blood or bone marrow …

Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension

…, J Chen, A Babicheva, PP Jain… - … of Physiology-Cell …, 2021 - journals.physiology.org
Piezo is a mechanosensitive cation channel responsible for stretch-mediated Ca 2+ and Na
+ influx in multiple types of cells. Little is known about the functional role of Piezo1 in the …

Laparoscopic O'Conor's repair for vesico-vaginal and vesico-uterine fistulae.

PJ Chibber, HN Shah, P Jain - BJU international, 2005 - search.ebscohost.com
This article cites a study investigating the effectiveness of laparoscopic O'Corner's repair for
vesico-vaginal and vesico-uterine fistulae. Vesico-vaginal fistula (VVF) has been a social …